The groundbreaking therapy of tirzepatide peptide represents a major breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts dual pathways – GLP-1 and GIP – leading to greater sugar management and anticipated weight reduction. Experts are investigating its p… Read More